Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7A | Q13946 | 4/20 | 0.47 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | RHEB | Q15382 | 3/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17847501 | 0.81 | CYP3A4 (0.41) | L3MBTL1MAPK1MEN1KMT2ALMNA | |
| SCHEMBL19712961 | 0.81 | ALDH1A1 (0.38) | PDE7APDE7BL3MBTL1MAPK1RHEB | |
| SCHEMBL28467702 | 0.80 | SLC6A2 (0.50) | PDE7APDE7BL3MBTL1RHEBSLC6A4 | |
| SCHEMBL19712975 | 0.80 | SLC6A4 (0.38) | MAPK1SLC6A4SLC6A2SLC6A3MEN1 | |
| SCHEMBL624408 | 0.80 | CYP3A4 (0.44) | L3MBTL1MAPK1MEN1KMT2ALMNA | |
| SCHEMBL17847448 | 0.80 | CYP3A4 (0.33) | PDE7APDE7BSLC6A4SLC6A2SLC6A3 | |
| SCHEMBL17847474 | 0.78 | GABRA1 (0.36) | L3MBTL1MAPK1SLC6A4SLC6A2KMT2A | |
| SCHEMBL17847456 | 0.77 | CYP3A4 (0.41) | L3MBTL1MAPK1MEN1KMT2ALMNA | |
| SCHEMBL17847452 | 0.76 | CYP3A4 (0.42) | MAPK1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL19712993 | 0.76 | HTR2C (0.34) | SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107223121-B | Wet stable holographic media | 科思创德国股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-3233791-B1 | MOISTURE STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2020-08-12 | — | — | EP | disclosed |
| US-10329244-B2 | Moisture-stable holographic media | COVESTRO DEUTSCHLAND AG (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | COVESTRO DEUTSCHLAND AG (DE) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329244-B2 | Moisture-stable holographic media | NEFM, MDM4, BHMT2 | PDE7A 4117/4885PDE7B 3557/4885L3MBTL1 4042/4885 |
| US-20170362165-A1 | MOISTURE-STABLE HOLOGRAPHIC MEDIA | NEFM, MDM4, BHMT2 | PDE7A 4117/4885PDE7B 3557/4885L3MBTL1 4042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.